HAMILTON, Mont. (AP) Work is nearly complete on a 137 million dollar expansion to the Glaxo-Smith-Kline biotechnology plant in Hamilton.The expansion will allow the company to triple its production of a component added to vaccines to enhance their effectiveness.
